Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Merino

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Anales De Pediatria|January 6, 2020
[Immunisation schedule of the Spanish Association of Paediatrics: 2020 recommendations]Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, et al.
Atencion Primaria|June 22, 2014
[Childhood and adolescence program]Julia Colomer Revuelta, Olga Cortes Rico, María Jesús Esparza Olcina, et al.
Atencion Primaria|June 6, 2018
Ana Martínez Rubioa, Olga Cortés Rico, Carmen Rosa Pallás Alonso, et al.
The Pediatric Infectious Disease Journal|June 10, 2008
Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of ageJuan C Tejedor, Manuel Moro, José Manuel Merino, et al.
The Pediatric Infectious Disease Journal|December 22, 2016
Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants: An Open, Randomized TrialJose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, et al.
The Pediatric Infectious Disease Journal|April 6, 2018
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants: Results of an Open, Randomized TrialJose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, et al.
The Pediatric Infectious Disease Journal|July 26, 2012
Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccineJuan Carlos Tejedor, José Manuel Merino, Manuel Moro, et al.
The Pediatric Infectious Disease Journal|July 29, 2006
Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccineJuan C Tejedor, Manuel Moro, Jesus Ruiz-Contreras, et al.
The Pediatric Infectious Disease Journal|January 2, 2007
Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine coadministered with a Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 monthsJuan C Tejedor, Manuel Moro, Jesús Ruiz-Contreras, et al.
The Journal of Infectious Diseases|July 21, 2023
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized TrialXavier Sáez-Llorens, Ximena Norero, Marisa Márcia Mussi-Pinhata, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Anales De Pediatria|January 6, 2020
[Immunisation schedule of the Spanish Association of Paediatrics: 2020 recommendations]Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, et al.
Atencion Primaria|June 22, 2014
[Childhood and adolescence program]Julia Colomer Revuelta, Olga Cortes Rico, María Jesús Esparza Olcina, et al.
Atencion Primaria|June 6, 2018
Ana Martínez Rubioa, Olga Cortés Rico, Carmen Rosa Pallás Alonso, et al.
The Pediatric Infectious Disease Journal|June 10, 2008
Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of ageJuan C Tejedor, Manuel Moro, José Manuel Merino, et al.
The Pediatric Infectious Disease Journal|December 22, 2016
Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants: An Open, Randomized TrialJose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, et al.
The Pediatric Infectious Disease Journal|April 6, 2018
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants: Results of an Open, Randomized TrialJose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, et al.
The Pediatric Infectious Disease Journal|July 26, 2012
Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccineJuan Carlos Tejedor, José Manuel Merino, Manuel Moro, et al.
The Pediatric Infectious Disease Journal|July 29, 2006
Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccineJuan C Tejedor, Manuel Moro, Jesus Ruiz-Contreras, et al.
The Pediatric Infectious Disease Journal|January 2, 2007
Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine coadministered with a Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 monthsJuan C Tejedor, Manuel Moro, Jesús Ruiz-Contreras, et al.
The Journal of Infectious Diseases|July 21, 2023
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized TrialXavier Sáez-Llorens, Ximena Norero, Marisa Márcia Mussi-Pinhata, et al.
Pageof 5